by [email protected] | Jan 31, 2022 | Blog
For years, market access teams within the biopharmaceutical industry have relied on regional, state and national medical and pharmacy covered lives data to size and scale their markets, identify targets, and set priorities for their strategy and contract negotiations....
by [email protected] | Jan 4, 2022 | Blog
Real-world data (RWD) and real-world evidence (RWE) are transforming the future of healthcare, including how Health Economics & Outcomes Research (HEOR) reveals the true burden of disease. Clinical trial data and payer-limited datasets are not enough to fully...
by [email protected] | Jun 18, 2021 | Blog, Uncategorized
June 18, 2021 Choosing the right data to answer research questions is important, especially when it comes to developing an external control arm. External comparators or controls (also known as historical controls) have the potential to improve the evaluation of novel...
